VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 624 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $461,000 | +738.2% | 39,179 | +50.2% | 0.04% | +780.0% |
| Q1 2022 | $55,000 | -23.6% | 26,081 | +0.4% | 0.01% | -28.6% |
| Q4 2021 | $72,000 | -95.6% | 25,969 | -80.9% | 0.01% | -97.4% |
| Q2 2020 | $1,635,000 | +1969.6% | 136,000 | +164.7% | 0.27% | +1405.6% |
| Q1 2020 | $79,000 | -94.6% | 51,388 | -94.7% | 0.02% | -85.8% |
| Q4 2019 | $1,464,000 | -80.0% | 971,217 | +18.7% | 0.13% | -93.2% |
| Q3 2019 | $7,314,000 | – | 818,000 | – | 1.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |